Work

Phase I study to evaluate toxicity and feasibility of intratumoral injection of alpha-gal glycolipids in patients with advanced melanoma.

Year: 2014

Type: conference-abstract

Source: Journal of Clinical Oncology

DOI: 10.1200/jco.2014.32.15_suppl.3088

Authors: Mark R. Albertini, Erik Ranheim, Cindy Zuleger, Paul M. Sondel, Jacquelyn A Hank, Alan Bridges, Michael Newton, Thomas McFarland, Jennifer Collins, Erin Clements, MaryBeth Henry, Heather B. Neuman, Sharon M. Weber, Giles Francis Whalen, Uri Galili

Institutions: University of Wisconsin–Madison, University of Wisconsin Carbone Cancer Center, UMass Memorial Health Care, UMass Memorial Medical Center, University of Massachusetts Chan Medical School

Language: English

Topic: Immunotherapy and Immune Responses

Subfield: Immunology

Field: Immunology and Microbiology

Domain: Life Sciences

SDG: Good health and well-being

Open Access status: closed

OpenAlex ID: W2602264718

Cites:

Cited by: 1

Related to: 10